Senores Pharmaceuticals (SENORES.NS) Earnings Analysis

Senores Pharmaceuticals (SENORES.NS) next reports earnings on 2026-07-27, consensus EPS 5.81 INR. Last quarter (2026-05-14) it beat with EPS 6.9 INR vs 6.29 INR est (+9.7%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 52.69.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SENORES.NS next report earnings?

Next earnings date2026-07-27
Consensus EPS estimate5.81 INR
Revenue estimate1.93B

SENORES.NS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-146.9 INR6.29 INR+9.7%Beat
2026-01-206.9 INR6.12 INR+12.7%Beat

Beat rate: 2/2 (100%) over reported quarters with consensus data.

SENORES.NS valuation and analyst view

Trailing P/E52.69
Trailing EPS29.055 INR
Price / book5.91
Dividend yield0.00%
Market cap64.17B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Senores Pharmaceuticals (SENORES.NS)'s next earnings date?

Senores Pharmaceuticals is next scheduled to report on 2026-07-27, with a consensus EPS estimate of 5.81 INR and revenue estimate of 1.93B.

Did SENORES.NS beat earnings last quarter?

In its 2026-05-14 report, SENORES.NS posted EPS of 6.9 INR versus a 6.29 INR estimate — a beat of 9.7%.

What is SENORES.NS's earnings track record?

Over the last 2 reported quarters with consensus data, SENORES.NS beat estimates 2 times (100%).

What is SENORES.NS's current P/E ratio and EPS?

SENORES.NS trades at a trailing P/E of 52.69 on trailing EPS of 29.05488156887295 INR.

What do analysts rate SENORES.NS?

SENORES.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.